Having validated IGFBP3 and IGBFP5 as markers of RCC-associated TECs and NECs, respectively, we examined the expression profiles of these genes in tumor and normal tissues in The Cancer Genome Atlas (TCGA) dataset. The gene discussed is IGFBP3; the disease is neoplasm.